Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 75 institutions that hold shares in the stock, with a total of 114 Million shares, which have been reported (via 13F filing form) to have a value of $32 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
78,031
shares
|
$21,848
0.0% of portfolio
|
Q1 2025
Added 23.2%
|
|
|
State Of Tennessee, Treasury Department
Nashville, TN |
May 13, 2025 Q1 2025 |
73,376
shares
|
$20,545
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
May 12, 2025 Q1 2025 |
65,058
shares
|
$18,216
0.0% of portfolio
|
Q4 2024
Reduced 59.18%
|
|
|
Sei Investments CO
Oaks, PA |
May 14, 2025 Q1 2025 |
54,824
shares
|
$15,350
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
State Of New Jersey Common Pension Fund D
|
May 13, 2025 Q1 2025 |
54,718
shares
|
$15,321
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
May 15, 2025 Q1 2025 |
53,186
shares
|
$14,892
0.0% of portfolio
|
Q1 2025
Added 6944.5%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
51,333
shares
|
$14,373
0.0% of portfolio
|
Q3 2024
Reduced 1.02%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
50,068
shares
|
$14,019
0.0% of portfolio
|
Q1 2025
Added 0.01%
|
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
40,700
shares
|
$11,396
0.0% of portfolio
|
Q1 2025
Reduced 36.37%
|
|
|
Columbia Advisory Partners LLC
|
Apr 15, 2025 Q1 2025 |
36,530
shares
|
$10,228
0.01% of portfolio
|
Q1 2025
Added 122.47%
|
|
|
Css LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
30,702
shares
|
$8,596
0.0% of portfolio
|
Q4 2023
Reduced 66.15%
|
|
|
Simon Quick Advisors, LLC
|
Apr 15, 2025 Q1 2025 |
30,000
shares
|
$8,400
0.0% of portfolio
|
Q4 2024
Reduced 1.48%
|
|
|
Newman Dignan & Sheerar, Inc.
|
Jul 18, 2025 Q2 2025 |
27,957
shares
|
$7,827
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Legacy Capital Wealth Management, LLC
The Woodlands, TX |
Jun 04, 2025 Q4 2024 |
27,080
shares
|
$7,582
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Stifel Financial Corp
St. Louis, MO |
May 13, 2025 Q1 2025 |
26,469
shares
|
$7,411
0.0% of portfolio
|
Q4 2024
Reduced 4.16%
|
|
|
Hsbc Holdings PLC
London, X0 |
May 14, 2025 Q1 2025 |
26,064
shares
|
$7,297
0.0% of portfolio
|
Q1 2024
Reduced 1.66%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
May 13, 2025 Q1 2025 |
25,261
shares
|
$7,073
0.0% of portfolio
|
Q1 2025
Reduced 18.73%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
21,966
shares
|
$6,150
0.0% of portfolio
|
Q1 2025
Added 12.47%
|
|
|
Prosperity Wealth Management, Inc.
San Ramon, CA |
Apr 18, 2025 Q1 2025 |
19,798
shares
|
$5,543
0.0% of portfolio
|
Q1 2025
Reduced 9.47%
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
18,313
shares
|
$5,127
0.0% of portfolio
|
Q4 2024
Added 7.84%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
17,344
shares
|
$4,856
0.0% of portfolio
|
Q1 2025
Reduced 40.5%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
16,149
shares
|
$4,521
0.0% of portfolio
|
Q1 2025
Reduced 0.07%
|
|
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
Jul 10, 2025 Q2 2025 |
14,935
shares
|
$4,181
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Ausdal Financial Partners, Inc.
Davenport, IA |
May 15, 2025 Q1 2025 |
12,476
shares
|
$3,493
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
X Square Capital, LLC
|
May 09, 2025 Q1 2025 |
11,173
shares
|
$3,128
0.0% of portfolio
|
Q4 2024
Reduced 0.06%
|